HTG Molecular’s access to Ingenuity’s unique bioinformatics platform allows researchers to combine data from disparate sources to gain an overall appreciation for the biology of the problem and potentially elucidate solutions and new biomarkers for therapeutic and diagnostic purposes. HTG Molecular’s analysts incorporate data derived from Ingenuity Systems IPA application and apply their depth of knowledge and experience to develop, verify and validate biomarkers on the array plate platform.

HTG Molecular’s Ingenuity Data Analysis allows the unparalleled ability to combine multivariant analysis of miRNA and mRNA targets from arrays. Please contact the HTG Molecular support team to learn how Ingenuity Data Analysis can be applied to any pharmaceutical clinical trial or study.